Rocket Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Rocket Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Rocket Pharmaceuticals Inc
Rating: 1.05758325
Author: Trendlyne DVM scores

about

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...

2.65 -0.05 (-1.85%)

51.38% Fall from 52W High

2.7M

XNAS Volume

XNAS 09 Jun, 2026 4:12 PM (EDT)

Board Meeting

The next board meeting for Rocket Pharmaceuticals Inc is on 18 Jun 2026 for the purpose of Rocket Pharmaceuticals Inc Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

12.3 / 100

Technically Bearish

30.0 / 100

No estimates available

Rocket Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rocket Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...

51.38% Fall from 52W High

SWOT Analysis

Rocket Pharmaceuticals Inc Live Price Chart